Evidence map›Paper›PMID 41793691›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2026

Impact of Optimization Resolution and Dose Calculation Grid Size in Small-Field Stereotactic Body Radiotherapy Using Flattening-Filter-Free Beams for Hepatocellular Carcinoma.

Moorthi Thirunavukkarasu, D Khanna, Karunakaran Balaji, Mohan Ramachandran

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Moorthi ThirunavukkarasuDepartment of Physics, Karunya Institute of Technology and Sciences, Coimbatore, India.ORCID 0009-0002-5163-6044
D KhannaDepartment of Physics, Karunya Institute of Technology and Sciences, Coimbatore, India.ORCID 0000-0015-2557-212X
Karunakaran BalajiDepartment of Oncology, Iswarya Hospital, Chennai, India.ORCID 0000-0002-1606-8769
Mohan RamachandranMediclinic Middle East, Dubai Healthcare City, Dubai, United Arab Emirates.ORCID 0009-0006-8384-6678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims to evaluate the impact of optimization and calculation resolutions in SBRT for hepatocellular carcinoma (HCC) using flattening-filter-free photon beams.

methodsThe SBRT plans were created in the Eclipse TPS using 6X-FFF and 10X-FFF MV photon beams, prescribed with a hypofractionated dose of 50 Gy in 5 fractions. A total of 4 plans were created for each energy with different combinations of optimization (O) and calculation (C) resolutions, viz. O1.25-C1.25, O1.25-C2.5, O2.5-C1.25, and O2.5-C2.5, using computed tomography (CT) images of fifteen HCC patients. The optimization and calculation times were noted for comparison among all plans. The plans were evaluated based on the PTV, organs at risk, and delivery efficiency dosimetric parameters, and a plan quality score was computed for each plan.

resultsThis study revealed that the 10X-FFF beams provided better results compared to 6X-FFF. The integrated scoring method revealed that the O1.25-C1.25 plan achieved better results for OARs, while O1.25-C2.5 plan achieved better results for PTV. Further, the optimization and calculation times, and phantom study results were better with 2.5 mm resolution plans.

conclusionThe 1.25 mm resolution for both optimization and calculation was found to be better if the critical organs are in prioritized; otherwise, the 2.5 mm resolution setting is the optimal choice for liver SBRT using the 10X-FFF beam.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsRadiosurgeryRadiotherapy Planning, Computer-AssistedFollow-Up StudiesHumansOrgans at RiskPhotonsPrognosisRadiotherapy DosageRadiotherapy, Intensity-Modulatedcalculation resolutionFFFLiver cancerSBRTVMAT

Identifiers

PMID41793691
PMCPMC13576479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.